1164 HEMOGLOBINE DECLINE DURING PEGINTERFERON ALFA-2B/RIBAVIRIN TREATMENT IN REAL-LIFE IS ASSOCIATED WITH FAVORABLE SVR RATES IN DIFFICULT-TO-TREAT PATIENTS WITH HCV GENOTYPE 1 INFECTION